Metastatic Colorectal Cancers Completed Phase 1 Trials for Dulanermin (DB12349)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00873756A Study of Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal CancerTreatment